ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm

Atherosclerosis

Volumn 202, Issue 1, 2009, Pages 205-210

  Lucarini, Laura ^a   Sticchi, Elena ^a,b   Sofi, Francesco ^a   Pratesi, Giovanni ^a   Pratesi, Carlo ^a   Pulli, Raffaele ^a   Gensini, Gian Franco ^a,b   Abbate, Rosanna ^a   Pepe, Guglielmina ^a   Fatini, Cinzia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Abdominal aortic aneurysm; ACE; AT1R; Genetic predisposition; TGFBR1 genes

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING HABIT;

AGED; AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS;

EID: 57649143132     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.04.038     Document Type: Article

References (32)

1. Fatini C., Pratesi G., Sofi F., et al. ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 29 (2005) 227-232
2. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105 (2000) 1605-1612
3. Habashi J.P., Judge D.P., Holm T.M., et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
4. Claridge M.W., Hobbs S.D., Quick C.R., et al. ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg 28 (2004) 67-70
5. Hackam D.G., Thiruchelvam D., and Redelmeier D.A. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 368 (2006) 659-665
6. Wolf G., Ziyadeh F.N., and Stahl R.A. Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. J Mol Med 77 (1999) 556-564
7. Gray M.O., Long C.S., Kalinyak J.E., Li H.T., and Karliner J.S. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40 (1998) 352-363
8. Pannu H., Tran-Fadulu V., and Milewicz D.M. Genetic basis of thoracic aortic aneurysms and aortic dissections. Am J Med Genet C: Semin Med Genet 139 (2005) 10-16
9. Pasche B., Luo Y., Rao P.H., et al. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 58 (1998) 2727-2732
10. Johnston K.W., Rutherford R.B., Tilson M.D., et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on reporting standards for arterial aneurysms, ad hoc committee on reporting standards, society for vascular surgery and north American chapter, international society for cardiovascular surgery. J Vasc Surg 13 (1991) 452-458
11. Cifkova R., Erdine S., Fagard R., et al. ESH/ESC hypertension guidelines committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21 (2003) 1779-1786
12. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106:3143-421.
13. Eagle K.A., Berger P.B., Calkins H., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). J Am Coll Cardiol 39 (2002) 542-553
14. Barnett H.J., et al. The appropriate use of carotid endoarterectomy. CMAJ 166 (2002) 1169-1179
15. Rigat B., Hubert C., Alhenc-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86 (1990) 1343-1346
16. Shih S.C., Ju M., Liu N., et al. Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo. Proc Natl Acad Sci USA 100 (2003) 15859-15864
17. Wolf Y.G., Rasmussen L.M., and Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest 93 (1994) 1172-1178
18. Shah P.K. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96 (1997) 2115-2117
19. Dai J., Losy F., Guinault A.M., et al. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation 112 (2005) 1008-1015
20. Mallat Z., Gojova A., Marchiol-Fournigault C., et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 89 (2001) 930-934
21. Massart F., Marini F., Menegato A., et al. Allelic genes involved in artery compliance and susceptibility to sporadic abdominal aortic aneurysm. J Steroid Biochem Mol Biol 92 (2004) 413-418
22. Lu S.L., Kawabata M., Imamura T., Miyazono K., and Yuasa Y. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene. Biochem Biophys Res Commun 259 (1999) 385-390
23. Disabella E., Grasso M., Marziliano N., et al. Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects. Eur J Hum Genet 14 (2006) 34-38
24. Pannu H., Fadulu V.T., Chang J., et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112 (2005) 513-520
25. Pasche B., Knobloch T.J., Bian Y., et al. Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 294 (2005) 1634-1646
26. Wolf G., Ziyadeh F.N., Zahner G., and Stahl R.A. Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogene. Kidney Int 48 (1995) 1818-1827
27. Thompson A.R., Drenos F., Hafez H., and Humphries S.E. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg 35 (2008) 19-30
28. Jones G.T., Thompson A.R., van Bockxmeer F.M., et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol 28 (2008) 764-770
29. Nagashima H., Uto K., Sakomura Y., et al. An angiotensin-converting enzyme inhibitor, not an angiotensin II type-1 receptor blocker, prevents beta-aminopropionitrile monofumarate-induced aortic dissection in rats. J Vasc Surg 36 (2002) 818-823
30. da Cunha V., Tham D.M., Martin-McNulty B., et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 178 (2005) 9-17
31. Hamdi H.K., and Castellon R. A genetic variant of ACE increases cell survival: a new paradigm for biology and disease. Biochem Biophys Res Commun 318 (2004) 187-191
32. Suehiro T., Morita T., Inoue M., et al. Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion. Hum Genet 115 (2004) 91-96